| 
Results for renalcancer. Search took 0.01 seconds.
Antisoma Recruits Patients for AS1411 Extended Phase I Trials
in The Biotech Weblog, on September 6, 2005
In a Phase I Clinical Trial involving 17 patients with various types of cancer, Antisoma 's drug candidate AS1411 showed promising anti-renal cancer activity. Antisoma was able to secure a U.S. orphan drug status for AS1411 in renal cancer, and is now recruiting 40 patients with renal...